相关实验视频
Updated: Jun 18, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
新的门诊糖尿病治疗方法和技术
Nevin Kamal1, Kristen Lee1, Grazia Aleppo1
1Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, Suite 530, Chicago, IL, USA.
The Medical clinics of North America
|July 31, 2024
概括
新的糖尿病药物,如GLP-1RA和SGLT2抑制剂,可以改善HbA1c,促进减肥,并为心血管/脏提供好处. 先进的糖尿病技术,包括连接的笔和自动化系统,增强了1型和2型糖尿病的胰岛素管理.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 医疗技术 医疗技术 医学技术
背景情况:
- 新兴的糖尿病药物提供了超出血糖控制的多方面的好处.
- 糖尿病技术的进步正在改变患者护理和胰岛素管理.
研究的目的:
- 审查新型糖尿病药物疗法的临床益处.
- 突出糖尿病技术在糖尿病管理中的不断扩大的作用.
主要方法:
- 最近临床研究和指导方针的文献综述.
- 对葡萄糖类-1受体激动剂 (GLP-1 RAs),依赖葡萄糖的胰岛素/GLP-1 RAs以及-葡萄糖共运输体2 (SGLT2) 抑制剂的数据分析.
- 评估胰岛素输送系统和连接设备的进步.
主要成果:
- GLP-1 RAs和双GIP/GLP-1 RAs显示出显著的HbA1c降低,体重减轻和心血管方面的优势.
- SGLT2 抑制剂提供 HbA1c 降低,心血管保护和保护作用.
- 糖尿病技术,包括连接的胰岛素笔和自动胰岛素输送,越来越多地被整合到2型和1型糖尿病管理中.
结论:
- 新型药物疗法为糖尿病管理提供了全面的好处.
- 糖尿病技术正在彻底改变胰岛素治疗,改善患者的治疗结果和坚持治疗.
- 先进的药物和技术的结合代表了糖尿病护理的未来.
相关概念视频
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K

